S. Saegusa et al., Leukotriene D-4-induced Rho-mediated actin reorganization in human bronchial smooth muscle cells, EUR J PHARM, 413(2-3), 2001, pp. 163-171
We investigated the role of cysteinyl leukotriene (CysLT) receptors an leuk
otriene D-4-induced actin reorganization and the signaling pathways of the
response in human bronchial smooth muscle cells. The effects of leukotriene
D-4 on actin reorganization in human bronchial smooth muscle cells were ev
aluated by dual-fluorescence labeling of filamentous (F) and monomeric (G)
actin with fluorescein isothiocyanate (FITC)-labeled phalloidin and Texas R
ed-labeled DNase I, respectively. Leukotriene D-4 (100 nM) induced actin re
organization in the presence and absence of extracellular Ca2+. The CysLT t
ype 1 (CysLT(1)) receptor antagonist ONO 1078 (4-oxa-8(-)[p-(4-phenylbutylo
xy) benzoylamino]-2-(tetrazol-5-yl)-4H-1-benzopyran hemihydrate) inhibited
leukotriene D-4-induced actin reorganization. Pretreatment with pertussis t
oxin, C3 exoenzyme, or tyrosine kinase inhibitors significantly reduced leu
kotriene D-4-induced actin reorganization. However, phosphatidylinositol-3-
kinase and protein kinase C inhibitors had little effect on these responses
. These results suggest that leukotriene D-4-induced actin reorganization i
n human bronchial smooth muscle cells is extremely dependent on the CysLT(1
) receptor coupled with pertussis toxin-sensitive G protein, Rho GTPases an
d tyrosine phosphorylation pathways. (C) 2001 Published by Elsevier Science
B.V.